OHC and The Jewish Hospital-Mercy Health Blood Cancer Center Boost Access to Clinical Trials
There are many misperceptions about clinical trials and the benefits they provide individuals battling cancer. As the leading provider of clinical trials in the tri-state area, OHC continues to invest resources in providing and educating the community to overcome barriers to enrollment.
Last year, OHC expanded its relationship with Mercy Health to become the official research partner of the Blood Cancer Center (BCC), providing more patients with greater access to innovative new drugs without having to travel far from home. Since October 2015, clinical research participation in blood cancer studies at the BCC has increased by more than 50 percent.
The partnership gives patients at the Blood Cancer Center access to clinical trials being conducted by OHC and its world-renowned strategic partner, Sarah Cannon Research Institute in Nashville, Tennessee.
This partnership is one of the many reasons that OHC is one of only six community oncology practices in the country recognized by the Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO) for its commitment to high-quality clinical trial programs.
You can read more about the partnership’s initiatives to boost access to clinical trials in The Business Courier.